Back to Awarded Treatment Trials


Awarded Trial: 14T-003

Grant ID

14T-003

Illness

schizophrenia

Primary Drug/Intervention

minocycline

Primary Dosage

200 mg/day

Secondary Drug Intervention

omega-3

Secondary Dosage

1.2 g/day

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Enrolling

Investigator

Qurashi

Sample Size

320

Duration of Study Period for Each Subject

365

Outcome Measurements

Transition rates in each group (as indexed by the Comprehensive Assessment of At Risk Mental State), as well as cognitive, social and occupational functioning.

Results

N/A

Publication

N/A

Link

N/A

PI Name

Qurashi

Degree

N/A

Center

Ashworth Research Centre

Institution

Mersey Care NHS Trust

Address

Parkborn

City or Town

Maghull

State or Province

Merseyside

Zip or Postal Code

L31 1HW

Country

United Kingdom

Email Address

inti.qurashi@merseycare.nhs.uk